MoneyMasters Podcast 🎙️ 1/22/26: Dave Nadig on How to Sort Through 5,000 ETFs

Mike Larson | Editor-in-Chief

With more than 5,000 ETFs on the market, figuring out which ones are right for you has become increasingly challenging.

On this episode of the MoneyShow MoneyMasters Podcast, we caught up with industry expert Dave Nadig to break down what’s really happening inside the ETF boom.

He explains how and why ETFs have become the default way investors get market exposure, which new innovations are fueling growth, and the benefits and drawbacks of various funds. Among those covered: Buffered ETFs, option-income funds, and leveraged products.

Dave has been around since the earliest days of ETFs, with leadership roles at ETF.com, FactSet, and Barclays Global Investors. He’s seen innovation create value and he’s seen it create traps.

Bottom line? ETFs can be powerful tools, or expensive distractions. This episode helps you tell the difference.

Reminder: Dave will be speaking at the 2026 MoneyShow/TradersEXPO Las Vegas, scheduled for Feb. 23-25. Click HERE to register.

Gibbs and Polcari Break Down Their “Top Picks” for ‘26!

In this recent episode of the MoneyShow MoneyMasters Podcast, Kenny Polcari and Erin Gibbs of SlateStone Wealth break down how they are approaching the market as leadership broadens and fundamentals start to matter more — and talk about their “Top Picks” for ‘26.

Reminder: It’s not too late to get your FREE copy of our MoneyShow 2026 Top Picks Report — with 68 investment ideas from 39 experts. Click HERE for yours. 

Want to Kick the Tires at MoneyShow Las Vegas? Claim a FREE Exhibit Hall Pass!

Wondering if the 2026 MoneyShow/TradersEXPO Las Vegas is right for you Then consider testing the waters at no cost – with a FREE Exhibit Hall Pass!

You can sample more than 60 expert presentations on stocks, trading, technology trends, and alternative investments. You can visit dozens of sponsor and exhibitor booths packed with trading products and services and investment opportunities. You can mix and mingle with 1,000+ fellow investors, traders, and other attendees. And if you decide you want access to EVERYTHING we offer, you can always upgrade on-site!

• Top Picks 2026: Eli Lilly & Co. (LLY)
  👉️ TICKER: NVDA, LLY
  Eli Lilly & Co. (LLY) needs little introduction, as it’s probably the most popular drug stock in the world right now thanks to Mounjaro (diabetes) and Zepbound (weight loss), which are the same drug selling well under both indications. But we still think the stock can surprise on the upside going forward, says Mike Cintolo, chief investment strategist at Cabot Wealth Network.

🎰 📈 Prime your portfolio for maximum profit in 2026—at the MoneyShow/TradersEXPO Las Vegas! Click HERE to join 100+ experts for three days of education and fun, Feb. 23-25, 2026, at the Paris Las Vegas!